Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novasenta
Pittsburgh, Pennsylvania, United Statesnovasenta.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Novasenta is developing novel cancer therapeutics by mapping the tumor microenvironment to discover druggable targets. The company has three nominated programs in development, with plans to move at least one into clinical trials by 2024.
- Therapeutic areas
- Oncology
- Modalities
- Immunotherapies
- Industry
- Biotech
02
Partnerships
UPMCUniversity of Pittsburgh
Beyond the preview
Go deeper on Novasenta.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novasenta.